Evaluation of allelic forms of the erythrocyte binding antigen 175 (EBA-175) in Plasmodium falciparum field isolates from Brazilian endemic area by Perce-da-Silva, Daiana S et al.
RESEARCH Open Access
Evaluation of allelic forms of the erythrocyte
binding antigen 175 (EBA-175) in Plasmodium
falciparum field isolates from Brazilian
endemic area
Daiana S Perce-da-Silva
1, Dalma M Banic
1, Josué C Lima-Junior
2, Fátima Santos
3, Cláudio T Daniel-Ribeiro
1,
Joseli de Oliveira-Ferreira
2 and Lilian R Pratt-Riccio
1*
Abstract
Background: The Plasmodium falciparum Erythrocyte Binding Antigen-175 (EBA-175) is an antigen considered to
be one of the leading malaria vaccine candidates. EBA-175 mediates sialic acid-dependent binding to glycophorin
A on the erythrocytes playing a crucial role during invasion of the P. falciparum in the host cell. Dimorphic allele
segments, termed C-fragment and F-fragment, have been found in high endemicity malaria areas and associations
between the dimorphism and severe malaria have been described. In this study, the genetic dimorphism of
EBA-175 was evaluated in P. falciparum field isolates from Brazilian malaria endemic area.
Methods: The study was carried out in rural villages situated near Porto Velho, Rondonia State in the Brazilian
Amazon in three time points between 1993 and 2008. The allelic dimorphism of the EBA-175 was analysed by
Nested PCR.
Results: The classical allelic dimorphism of the EBA-175 was identified in the studied area. Overall, C-fragment
was amplified in a higher frequency than F-fragment. The same was observed in the three time points where
C-fragment was observed in a higher frequency than F-fragment. Single infections (one fragment amplified) were
more frequent than mixed infection (two fragments amplified).
Conclusions: These findings confirm the dimorphism of EBA175, since only the two types of fragments were
amplified, C-fragment and F-fragment. Also, the results show the remarkable predominance of CAMP allele in the
studied area. The comparative analysis in three time points indicates that the allelic dimorphism of the EBA-175 is
stable over time.
Background
Malaria is an important parasitic disease responsible for
around one million deaths per year, especially in devel-
oping countries [1]. Among the five species of Plasmo-
dium responsible for human infection, Plasmodium
falciparum i st h em o s tv i r u l e n ts p e c i e s ,m a i n l yb yw i d e
spectrum of clinical complications. Considering the
number of malaria cases and the increasing resistance of
the Plasmodium to anti-malarial drugs [2-5] and the
resistance of Anopheles spp. to insecticides [6,7] the
control of malaria transmission remains a challenge.
Thus, in recent years, efforts have been focused on
developing a vaccine, especially against P. falciparum,
the species responsible for severe malaria and mortality.
One approach to developing a malaria vaccine is focused
on preventing the interaction between merozoite surface
ligands and the erythrocyte receptors, a short period in
which the parasite is vulnerable to attack by the
immune system [8].
One of the major antigens of P. falciparum merozoites
uses a 175-kDa sialic acid-binding protein ligand to
invade the host erythrocyte and this protein is known as
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175 is localized in the micronemes in the terminal end
of the merozoite and has been well characterized as the
ligand that binds glycophorin A (gyp A), present in the
erythrocytes membrane [11]. The eba-175 gene is
located on chromosome 7 and comprises four exons
and seven regions, named I to VII. The region III is
located in the central part of the gene and studies have
shown a highly dimorphic segment in this region. This
dimorphism is characterized by the insertion of a seg-
ment of 423 base pairs (bp) in strain FCR3 (F-fragment)
or a segment of 342 bp in strain CAMP (C-fragment).
These two variants are conserved among strains of P.
falciparum, and considering that the merozoites are
haploid and eba-175 is a single copy gene, either one or
the other segment is present in a uniclonal infection
[12-14]. The role of this dimorphism in the host-parasite
interactions, for example potential difference in effi-
ciency of red blood cell invasion related to genotype,
remains unclear [15]. However, it has been documented
that the binding of region II of the EBA175 molecule to
the sialic acid from glycophorin A, is following by pro-
teolitic cleavage of EBA175 and therefore binding of the
dimorphic C and F segments to the glycophorin back-
bone [12,16].
Several studies performed in malaria hyperendemic
areas in Africa have shown the influence of this
dimorphism, more precisely EBA175 allele distributions,
on clinical disease and outcome [11,13,14]. The differ-
ences observed between endemic areas of Brazil and
Africa in relation to exposed individuals and the circu-
lating parasites are important factors in terms of vaccine
strategies since the efficacy of a potential vaccine may
vary in different epidemiological scenarios. The goal of
this study was to evaluate the genetic dimorphism of
the EBA-175 in P. falciparum isolates from Rondonia
State, a Brazilian malaria endemic area.
Methods
Study site
The study was carried out in rural villages situated near
Porto Velho, the capital of Rondonia State, malaria
endemic region in the Brazilian Amazon (Figure 1). In
this region, malaria transmission is unstable, with
increased number of cases being detected annually
between April to September, and the risk of infection is
high [17]. This region became the target of a large influx
of people from other Brazilian regions during the 70 s
and 80 s. The population in these villages is composed
of natives and Brazilian migrants inhabiting this area for
variable periods of time since the 1970 s. The blood
samples were collected in three time points between
1993 and 2008. The first sample set was collected in
1993/1994 (time point-1), the second sample set was
obtained eight years later, in 2001/2002 (time point-2)
and the third sample set was obtained in 2007/2008
(time point-3). The average annual parasite incidence
(API) in these villages was 549 in 1993, 173 in 2002 and
85 in 2008. For reference, the Brazilian Ministry of
Health considers high-risk areas those with API ≥ 50.
Patients and isolates
Written informed consent was obtained from all donors
and venous blood samples were taken from P. falci-
parum infected individuals: 101 in time point-1, 57 in
time point-2 and 30 in time point-3. Samples from the
three time points were used in order to evaluate
whether the allelic dimorphism of the EBA-175 in Brazil
was present and if this dimorphism is temporally stable
in the same area. All P. falciparum malaria patients
enrolled in this study presented uncomplicated malaria
symptoms; positive thick blood smear for P. falciparum
and were not under chemoprophylaxis nor took anti-
malarial drugs (self-treatment). Blood collection was
performed on the day of diagnosis before malaria treat-
ment and the patients sought health care at Brazilian
health services 3.6 ± 1.8 days after onset of symptoms.
After blood sample collection, the patients were imme-
diately treated according to Brazilian Ministry of Health
standards for malaria therapy. The study was reviewed
and approved by the Fundação Oswaldo Cruz Ethical
Committee.
Thin and thick blood smears were examined for iden-
tification of malaria parasite by a technician experienced
in malaria diagnosis from Brazilian Malaria Health Ser-
vices and from the Laboratory of Malaria Research (Fio-
cruz) which is a reference in malaria diagnosis from
Brazilian Ministry of Health. Thick blood smears from
all subjects were stained with Giemsa, and a total of 200
Figure 1 Map of Brazil and Rondonia state.
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nification. Thin blood smears of positive samples were
examined for species identification. Only patients
infected with P. falciparum in the thick and thin blood
smears were enrolled in the study. The P. falciparum
parasite density was determined by counting parasites in
a predetermined number of white blood cells in thick
blood films, and the number of blood parasites per
milliliter was calculated [18]. The fresh blood samples
were washed three times with 0.15 M phosphate-buf-
fered saline and pellet containing packed red blood cells
was mixed with equal volume of cryopreservation solu-
tion (0.9% NaCl/4.2% sorbitol/20% glycerol) and frozen
in liquid nitrogen (N2).
Amplification of region III of the EBA-175
In order to amplify the region III of the eba-175 gene,
the DNA present in 1 mL of cryopreserved blood was
extracted using the QIAamp DNA blood midi kit
(QIAgen) as described by the manufacturer and stored
at -20°C until amplification. The region III of the eba-
175 gene was amplified in a Nested PCR method as
described elsewhere [15] using the first set of primers
EBA1 5’-CAAGAAGCAGTTCCTGAGGAA-3’ (for-
ward) and EBA2 5’-TCTCAACATTCATATTAA-
CAATTC-3’(reverse) and the second set of primers
EBA3 5’-GAGGAAAACACTGAAATAGCACAC-3’
(forward) and EBA4 5’-CAATTCCTCC-AGACT
GTTGAACAT-3’(reverse). Three μLo fD N Aw a s
amplified in a 50 μL reaction volume containing 10
nmol of each deoxynucleotide triphosphate (dNTP,
Promega, Madison, WI USA), 10 pmol/μL of each pri-
mer (Invitrogen, USA), 1 U AmpliTaq
® DNA polymer-
ase (Applied Biosystem, Foster City, CA), 5 μLo f1 0 ×
PCR-Buffer (Applied Biosystem) and 2.5 mM of MgCl2
(Applied Biosystem). The Nested PCR reactions were
carried out using a GeneAmp
® PCR System 9700
(Applied Biosystem) for thirty cycles (1 min. at 94°C, 1
min. at 56°C and 2 min. at 72°C). Fifteen μLo fP C R -
product were loaded onto a 2% agarose gel (LGC Bio-
tecnologia Ltda) in 1× TAE buffer (0.04 M TRIS-acet-
ate, 1 mM EDTA) in the presence of ethidium
bromide (0.5 μg/mL).
Statistical analysis
The data were stored in the Fox-plus
® (Borland Interna-
tional, Inc. Perrysburg, OH) data bank software. Statis-
tica (Microsoft, Inc. Redmond, WA) and Epi-Info 6
(Centers for Disease Control and Prevention, Atlanta,
GA) statistical software programs were used for data
analysis. The Student’s t-test was used to analyse the
differences in mean values and the chi-square test was
used to analyse the difference in prevalence of allelic
frequencies.
Results
Characteristics of the studied groups
Throughout the study period, a total of 188 P. falci-
parum samples were collected from malaria patients in
time point-1 (n = 101), time point-2 (n = 57), and time
point-3 (n = 30). The composition of individuals in the
three time points was similar regarding gender. Males
were predominant in three time points, 69%, 83% and
77% in the time points-1, -2 and -3, respectively. The
average age was also similar among individuals in time
point-1 (31 ± 13 years old), time point-2 (29 ± 11 years
old) and time point-3 (31 ± 10 years old). As expected,
the time of residence of individuals in the endemic
regions was higher in the time point-3 (28 ± 12) than in
the time point-1 (12 ± 9) and time point-2 (19 ± 9) (P <
0.0001, for both). The means parasitaemia at the time of
blood collection were 7751 ± 8431, 2218 ± 738 and
3587 ± 3769 parasites/μL in the time points-1, -2 and
-3, respectively. In the time point-1 the mean parasite-
mia was higher than in time points-2 and -3 (P <
0.0001, time point-1 versus time point-2; P = 0.01, time
point-1 versus time point-3).
Dimorphism of the EBA-175
The two types of fragments were identified in the stu-
died area by Nested PCR, one of 714 bp, corresponding
to the C-fragment, and the other one of 795 bp, corre-
sponding to the F-fragment (Figure 2). The frequencies
of C-fragment and F-fragment in P. falciparum wild iso-
lates were, respectively, 83.2% and 16.8%. The predomi-
nance of the C-fragment was evident in the P.

             1            2                3              4                 5               6                7
Figure 2 Nested polymerase chain reaction of EBA-175
products. Lane 1: 200 bp molecular ladder; Lane 2: negative
control; Lane 3: PCR positive control (C-fragment); Lane 4: C-
fragment of 714 bp; Lane 5: F-fragment of 795 bp; Lane 6: Mixed
infection (F- and C-fragment); Lane 7: 200 bp molecular ladder.
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test).
The vast majority (98.4%, 185/188) of the P. falci-
parum isolates presented only one amplified fragment
(single infection), while both fragments were observed
in only 1.6% (3/188) of the isolates representing mixed
infections (P < 0.001, c
2 test).
A sc a nb es e e ni nT a b l e1 ,t h ef r e q u e n c i e so ft h eC -
and F-fragments were stable over time. In the time
point-1 the frequency of the C- and F-fragment were,
respectively, 83.2% (84/101) and 19.8% (20/101). Three
of the 101 isolates (3%) presented mixed infection. In
the time point-2 C- and F-fragment were observed in
82.5% (47/57) and 17.5% (10/57) of the isolates, respec-
tively, while in the time point-3 these frequencies were
93.3% (28/30) and 6.7% (2/30) for C- and F-fragments,
respectively. No mixed infection was observed in time
points-2 and -3. Predominance of the C-fragment was
evident in the P. falciparum samples from studied area
in the three time points (P < 0.0001, C-fragment versus
F-fragment, for 3 time points).
Discussion
The aim of this study was to investigate the allelic
dimorphism of the EBA-175 in P. falciparum isolates
from Brazilian malaria endemic area, Rondonia State, in
three different time points (time point-1: 1993/94; time
point-2: 2001/2002; time point-3: 2007/2008 in order to
evaluate whether the allelic dimorphism of the EBA-175
in Brazil was present and if this dimorphism is tempo-
rally stable in the same area. Two fragments, C-frag-
ment (714 bp) and F-fragment (795 bp), were identified
in the studied area. Overall, C-fragment (83.2%) was
observed in a higher frequency than F-fragment (16.8%).
This data differ from results reported by three indepen-
dent research groups in high endemicity malaria areas
of Ghana, Gabon and Burkina Faso where F-fragment
was observed in a higher frequency than C-fragment
[11,13,19]. Interesting, the results reported here are in
agreement with the results observed in low endemicity
malaria area of Sudan where C-fragment has been
shown to be the most common [20]. The lower fre-
quency of F-fragment in the studied area can be
explained by: immunological selection of these Plasmo-
dium populations in infected studied individuals and/or
genetic background of the human studied population
[21,22]. Also it can be speculated that a random selec-
tion may be the reason for this distribution of the EBA-
175 allelic frequencies.
The differences observed in the distribution of C-
and F-fragments among geographical regions could be
explained by random shifts in parasite allele frequen-
cies due to genetic drift in genetically isolated popula-
tions [13]. In this case, allele frequencies might be
predicted to change over time. Another hypothesis
would be that differences in the genetic background
among study population may select for different EBA-
175 alleles. In this case, allele frequencies might be
p r e d i c t e dt ob es t a b l eo v e rt i m e[ 2 3 ] .O n es t u d yp e r -
formed by Soulama and co-workers analysed the seaso-
nal distribution of the EBA-175 allelic forms in four
villages in Burkina Faso, where malaria transmission in
markedly seasonal, and showed that the distribution of
EBA-175 alleles were relatively stable over 8 months
[11]. In the present study, the distribution of C- and
F-fragments were analysed in three time points over 15
years. Similar allelic frequencies suggests that the dis-
tribution of these two EBA-175 allelic forms is stable
over time, corroborating the hypothesis that host
genetic background can influence the distribution of
t h eE B A - 1 7 5a l l e l i cf o r m s .
In areas of high P. falciparum genetic diversity, the
individuals have a higher probability of being infected
simultaneously with more than two clones of the para-
site, which has been called the multiclonal [24,25] or
mixed infection. Considering that the complexity of
infections, reflected by the number of mixed infections,
can increase the likelihood of cross-fertilization of Plas-
modium spp. in the mosquito and thus increase the
genetic diversity [26,27], the frequency of single and
mixed infections in P. falciparum isolates from studied
population was evaluated. In the present work, a low
frequency of mixed infection (3/181, 1.7%) was found.
These results are similar to a study with the P126 pro-
tein that reveals low frequency of mixed infection in
Brazilian isolates from the same area [28]. The three
mixed infections reported in the present work were
observed only in the time point-1. Probably these three
mixed infections were found due the high endemicity in
the studied area in the first year of sample set (API =
549) when compared with the second (API = 173) and
the third (API = 85) sample sets, since several studies
indicated that there is a positive relationship between
transmission intensity and complexity of infection
[29,30]. Alternatively, the lower sample size in time
points-2 and -3 may account for underestimation of
mixed infection.
Table 1 Infection patterns of the Plasmodium falciparum








1 98 (97%) 57 (100%) 30 (100%)
C-fragment 81 (80.2%)* 47 (82.5%)* 28 (93.3%)*
F-fragment 17 (16.8%) 10 (17.5%) 2 (6.7%)
Mixed infection
2 3 (3%) ——
1Isolates with one fragment;
2Isolates with two fragments; * P < 0,0001
C-fragment versus F-fragment.
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In conclusion, in the studied area, C-fragment is more
frequent than F-fragment. The comparative analysis of
the allelic dimorphism of the EBA-175 in P. falciparum
isolates from Rondonia State in three time points over
15 years suggest that the frequencies of the two allelic
forms remains stable over time. These data supports
the hypothesis of a biologically important role for
EBA-175 in parasite development and/or survival and
highlight the importance of evaluating the distribution
of EBA-175 allelic forms in different geographical
areas.
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